Study finds GLP-1 medicines cut fat while preserving muscle function
A new study in mice and humans suggests GLP-1 medicines drive weight loss primarily by reducing fat, while…
Key gene mutation disrupts the brain’s ability to update beliefs in schizophrenia patients
One of the symptoms of schizophrenia is difficulty incorporating new information about the world. This can lead patients…
Patients who stop GLP-1 drugs often restart or try alternatives
A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or…
Single receptor PAR1 controls opposing responses in blood vessels
Researchers at the University of California San Diego have uncovered how a single protein triggers two opposite responses…
Biomimetic platform enhances CAR T therapy for relapsed and refractory leukemia
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by…
Taking anticoagulants alongside prostate cancer drugs does not increase bleeding risk
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants, investigators found no evidence of an increase in patients’ bleeding or clotting…
Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit
A major study of US veterans suggests that GLP-1 diabetes medications may influence addiction-related outcomes, revealing a surprising…
Engineered lettuce may turn injectable GLP-1 therapies into oral pills
Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…
Mapping the year-one weight trajectory after stopping GLP-1s
A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain, on average, 60%…
How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…
Blocking growth hormone receptor may improve treatment response in lung cancer
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is…
Mendelian randomization study reveals opposing roles for IL6 and IL6R in long-term mortality
A new research paper was published in Volume 18 of Aging-US on February 6, 2026, titled “Causal effects of inflammation on…